Dentsply Sirona, Inc.
Investors that purchased the Company’s securities and have suffered a loss, please fill in transaction information below, or email to info@portnoylaw.com.
There is no cost or obligation associated with submitting your information. If you are a shareholder who suffered a loss, please submit your contact information and purchase information to participate in the putative class action.
We also encourage you to contact Lesley F. Portnoy of The Portnoy Law Firm, at 310.692.8883, to discuss your rights free of charge. You can also reach us through the firm’s website at www.portnoylaw.com, or by email at info@portnoylaw.com.
If you choose to take no action, you can remain an absent class member.
Joining the case through the Portnoy Law website enables investors to learn about their legal claims and take an active role in recovering their losses.
The Portnoy Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
CONTACT:
Portnoy Law Firm
Lesley F. Portnoy, Esq.,
www.portnoylaw.com
Office: 310.692.8883
1800 Century Park East, Suite 600
Los Angeles, CA 90067
info@portnoylaw.com
The lawsuit, filed in the U.S. District Court for the Southern District of Florida, brings claims under sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) on behalf of a class comprising individuals who purchased Dentsply common stock between December 1, 2022, and November 6, 2024 (the “Class Period”) and suffered damages as a result (the “Class”).
The Complaint alleges that during the Class Period, Defendants made materially false and misleading statements and failed to disclose significant negative information about the Company’s operations and future prospects. Specifically, it is claimed that Defendants did not inform investors that: (1) the Company’s Byte aligners had caused severe injuries to patients over several years; (2) the Company had not reported these injuries to the U.S. Food and Drug Administration (FDA); and (3) the financial value attributed to the Byte aligners was significantly overstated, among other issues.
When the truth came to light, the Complaint states that Dentsply’s stock price dropped by $6.72 per share, a decline of more than 28%, closing at $17.26 per share on November 7, 2024, resulting in losses for investors.
